Influence of alternating low frequency magnetic fields on reactivity of central dopamine receptors in neonatal 6-hydroxydopamine treated rats
Authors not listed · 2001
Magnetic field exposure reduced dopamine receptor function in rats with brain damage, suggesting EMF may worsen existing neurological conditions.
Plain English Summary
Researchers exposed rats with chemically-damaged dopamine neurons (modeling Parkinson's disease) to 10 Hz magnetic fields at 1.8-3.8 mT for one hour daily over 14 days. The magnetic field exposure reduced the brain's responsiveness to dopamine signaling, suggesting EMF can interfere with critical neurotransmitter systems already compromised by neurological disease.
Why This Matters
This study reveals a troubling interaction between EMF exposure and compromised neurological systems. The researchers found that 10 Hz magnetic fields - frequencies common in power line emissions - further impaired dopamine receptor function in rats already modeling Parkinson's disease. What makes this particularly concerning is the field strength used: 1.8-3.8 mT is thousands of times stronger than typical household exposures, yet it still produced measurable neurological effects.
The science demonstrates that EMF can interfere with neurotransmitter systems that are already vulnerable. While we can't directly extrapolate animal studies to humans, this research adds to growing evidence that electromagnetic fields may pose particular risks to individuals with existing neurological conditions. The reality is that people with Parkinson's disease and similar conditions may represent a more susceptible population when it comes to EMF exposure.
Exposure Information
Specific exposure levels were not quantified in this study.
Show BibTeX
@article{influence_of_alternating_low_frequency_magnetic_fields_on_reactivity_of_central_dopamine_receptors_in_neonatal_6_hydroxydopamine_treated_rats_ce4551,
author = {Unknown},
title = {Influence of alternating low frequency magnetic fields on reactivity of central dopamine receptors in neonatal 6-hydroxydopamine treated rats},
year = {2001},
doi = {10.1002/bem.76},
}